\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Association between Periodontitis and Severe Asthma: The Role of IgG Anti-Porphyromonas gingivalis levels},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2020-01-15 (revised: 15 January 2020)}
\def\TheID{\makeatother }
\def\TheDate{2020-01-15}
\title{Association between Periodontitis and Severe Asthma: The Role of IgG Anti-Porphyromonas gingivalis levels}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Soraya Castro  Trindade}

             \affil[1]{  Campus Universitário}

\renewcommand\Authands{ and }

\date{\small \em Received: 10 December 2019 Accepted: 31 December 2019 Published: 15 January 2020}

\maketitle


\begin{abstract}
        


Asthma and periodontitis are both very prevalent worldwide. Although the association between these diseases has been investigated, the biological mechanism underlying this association, especially the role of biological mediators, remains unclear. Thus, the aim of this study was to evaluate serum levels of anti-Porphyromonas gingivalis IgG in subjects with and without severe asthma. A case-control study involving 169 individuals consisted of subjects with severe asthma in addition to others without asthma (control group). An indirect enzyme linked immunosorbent assay (ELISA) was performed to measure serum levels of IgG specific to Porphyromonas gingivalis. Bacterial DNA was extracted from subgingival biofilm samples and real-time polymerase chain reaction (RTPCR) analysis was performed to quantify Porphyromonas gingivalis levels. No statistically significant differences were observed between case and control groups with respect to levels of IgG specific to Porphyromonas gingivalis whole extract (p=0.484) or rHmuY protein (p=0.903). The relative quantification of Porphyromonas gingivalis was similar between the groups with and without asthma (p=0.553). When participants were regrouped according to a diagnosis of periodontitis, no significant differences were detected between subjects with and without periodontitis, either in serum levels of IgG specific to Porphyromonas gingivalis whole extract (p=0.789) or specific to rHmuY (p=0.630). However, participants with chronic periodontitis had lower levels of Porphyromonas gingivalis in their biofilm than individuals without periodontitis (p=0.001). We hypothesize that the occurrence of asthma exerts an influence over Porphyromonas gingivalis colonization in the biofilm, as well as modulates the production of IgG specific to this pathogen in periodontitis.

\end{abstract}


\keywords{asthma, periodontitis, immunoglobulin G.}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{AssociationbetweenPeriodontitisandSevereAsthmaTheRoleofIgGAntiPorphyromonasgingivalislevels}]{AssociationbetweenPeriodontitisandSevereAsthmaTheRoleofIgGAntiPorphyromonasgingivalislevels} 
\section[{Strictly as per the compliance and regulations of:}]{Strictly as per the compliance and regulations of:}\par
Abstract-Asthma and periodontitis are both very prevalent worldwide. Although the association between these diseases has been investigated, the biological mechanism underlying this association, especially the role of biological mediators, remains unclear. Thus, the aim of this study was to evaluate serum levels of anti-Porphyromonas gingivalis IgG in subjects with and without severe asthma. A case-control study involving 169 individuals consisted of subjects with severe asthma in addition to others without asthma (control group). An indirect enzyme linked immunosorbent assay (ELISA) was performed to measure serum levels of IgG specific to Porphyromonas gingivalis. Bacterial DNA was extracted from subgingival biofilm samples and real-time polymerase chain reaction (RT-PCR) analysis was performed to quantify Porphyromonas gingivalis levels. 
\section[{I. Introduction}]{I. Introduction}\par
evere asthma and periodontitis are chronic diseases highly prevalent worldwide, affect individuals ? 18 years \hyperref[b0]{(1,}\hyperref[b1]{2)} . Asthma, an inflammatory disease affecting the airways, is characterized by increased bronchial responsiveness and reversible airflow limitations, i.e. frequent episodes of shortness of breath and gasping, thoracic oppression and coughing \hyperref[b1]{(2)} . Of the individuals affected by asthma, 10\% suffer from its severe form, leading to negative economic and social impacts. The recurrent suffocation experienced results in human suffering and decreases in quality of life \hyperref[b2]{(3)} .\par
Among the chronic diseases that are predominant nowadays, the relationship between asthma and oral health has been a relevant topic of discussion \hyperref[b3]{(4)} . The presence of chronic infections seems to influence the pathogenesis of asthma, and a wide range of phenotypes and endophenotypes have been observed \hyperref[b4]{(5)} .\par
Many studies have demonstrated a positive association between asthma and periodontitis \hyperref[b5]{(6)}\hyperref[b6]{(7)}\hyperref[b7]{(8)}\hyperref[b8]{(9)}\hyperref[b9]{(10)} . However, other studies found a negative association and attempted to explain this using the hygiene hypothesis. Accordingly, a high prevalence of oral infectious diseases may contribute to decreases in the incidence of asthma and other allergic diseases. Thus, exposure to oral bacteria, including periodontal disease pathogens, could play a protective role in the development of asthma and allergies by polarizing the immune response \hyperref[b12]{(13,}\hyperref[b13]{14)} .\par
Recently, a new model describing the pathogenesis of periodontitis was proposed, in which the onset of periodontal disease is promoted by a synergistic and dysbiotic microbial community, instead of a specific group of bacteria referred to as periodontopathogens. Some bacteria present at low levels in the microbiota can affect the entire community. Due to their important role in the development of dysbiosis, these are denominated "keystone pathogens" \hyperref[b14]{(15)} . Of these, one of the most studied is Porphyromonas gingivalis, a Gram-, strictly anaerobic and asaccharolytic bacterium belonging to the Bacteroidaceae family, has been consistently associated with human periodontitis \hyperref[b14]{(15,}\hyperref[b15]{16)} .\par
Confirming the role of Porphyromonas gingivalisin the etiology and pathogenesis of periodontitis, high levels of specific IgG against this bacteria were found in the sera of affected individuals \hyperref[b16]{(17,}\hyperref[b17]{18)} . Moreover, individuals with chronic periodontitis presented higher levels of IgG against Porphyromonas gingivalis antigens, such as HmuY and the gingipains proteinases, than healthy individuals, or those with gingivitis \hyperref[b16]{(17)}\hyperref[b17]{(18)}\hyperref[b18]{(19)}\hyperref[b19]{(20)}\hyperref[b20]{(21)} .\par
Due to the public health relevance of these two highly prevalent chronic diseases, asthma and periodontitis, and the gaps in knowledge regarding associations between them, specifically concerning the role of biological molecules, the present study aimed to investigate associations between these two chronic diseases, as well as to evaluate levels of IgG specific to the crude extract of Porphyromonas gingivalis, and HmuY, a lipoprotein of this bacteria. 
\section[{II. Material and Methods}]{II. Material and Methods} 
\section[{a) Study Design}]{a) Study Design}\par
The present non-matched case-control study was performed to evaluate the serum humoral immune response against Porphyromonas gingivalis in severe asthma. The case group consisted of individuals with severe asthma, while individuals in the control group did not have asthma. The case: control ratio was 1:2. 
\section[{b) Participants and study area}]{b) Participants and study area}\par
Asthmatic participants were enrolled at the ProAR clinic (Program for Asthma Control in Bahia), located in Salvador, Bahia, Brazil. This study was approved by the IRB of the Feira de Santana State University (protocol no. 43131615.3.0000.0053).\par
Study volunteers were informed of the research protocol and required to sign a term of free and informed consent. Interviews were conducted to obtain background information regarding socioeconomic status, medical history, lifestyle and health habits, as well as oral hygiene habits and frequency of dental visits. 
\section[{c) Selection criteria}]{c) Selection criteria}\par
Individuals were seen at the ProAR clinic, part of the multidisciplinary municipal health center (Centro de Saúde Carlos Gomes), located in Salvador, Bahia, Brazil, were selected based on a diagnosis of severe asthma. For each participant in the case group, two other nonasthmatic individuals were selected from the patient pool of the municipal health center for inclusion in the case group, provided they resided in the same neighborhood as the case participant. To not introduce bias, all control individuals were recruited from the dental services division of the municipal health center on days in which a periodontal specialist was not present. 
\section[{d) Sample size calculation}]{d) Sample size calculation}\par
Sample size was calculated based on a previously reported proportion of individuals with periodontitis (61.9\%) within a group of severe asthmatic patients versus 27.1\% in a group without asthma \hyperref[b5]{(6)} . Thus, considering an odds ratio of 4.37,a significance level of 95\%, a power of 80\% for two-tailed testing, and a case: control ratio of 1:2, the minimum sample size was 54 individuals for the CASE group and 108 individuals for the CONTROL group. 
\section[{e) Periodontal Diagnosis}]{e) Periodontal Diagnosis}\par
Individuals were considered to have periodontitis when at least four teeth presented one or more sites meeting all of the following conditions: probing depth ? 4mm, clinical attachment level ? 3mm, and bleeding on probing after stimulation \hyperref[b21]{(22)}  
\section[{f) Diagnosis of Severe Asthma}]{f) Diagnosis of Severe Asthma}\par
The diagnosis of asthma was made by GINA, 2012 \hyperref[b6]{7} . Before the inclusion, a revision in the medical records of each participant was realized, and only those who received a diagnosis by two specialists and confirmed by spirometry were included. 
\section[{g) Peripheral blood collection}]{g) Peripheral blood collection}\par
Peripheral blood (5 mL) was collected by venipuncture in the antecubital fossa from all participants and stored in Vacutainer tubes (BD, SP, Brazil) with clot activator. The tubes were centrifuged for 10 min to obtain sera, which was stored at -20º until analysis.\par
h) Antigen obtainment P. gingivalis ATCC33277 was grown in Brucella broth supplemented with menadione and L-cysteine, and then somatic immunogenic proteins were obtained by centrifugation (18). The recombinant protein HmuY (rHmuY) of Porphyromonas gingivalis was cloned from Escherichia coli using a plasmid as a cloning vector, then purified and characterized. 
\section[{i) ELISA to measure IgG against antigens of Porphyromonas gingivalis}]{i) ELISA to measure IgG against antigens of Porphyromonas gingivalis}\par
An enzyme linked immunosorbent assay (ELISA) was used to evaluate the humoral immune response against a crude extract of Porphyromonas gingivalis and the rHmuY protein using an indirect measure of IgG levels in the sera of the participants.\par
A 96-well plate was coated with 5µg/mL of antigen (P. gingivalis crude extract or rHmuY) and incubated overnight at 4ºC. After washing with phosphate-buffered saline (PBS), blocking was performed using 5\% skim milk (Molico, Araçatuba, Brazil). After reincubation for 2h at 37ºC, the plates were washed twice, and diluted sera (1:1000) was placed in each well, followed by an incubation period of 1h at 37ºC. All wells were then washed five times with PBS and reincubated with anti-human IgG conjugated with peroxidase (Sigma Aldrich, USA) diluted at 1:25000 for 1h at 37ºC. After five additional washes, a chromogenic substrate (H 2 O 2 -TMB) was added, and the reaction was stopped using 2N H 2 SO 4 . IgG levels were measured by optical density (OD) using a microplate reader (PR2100 Bio-Rad, USA) at wavelengths ranging from 450-620 nm. 
\section[{j) Biofilm Collection}]{j) Biofilm Collection}\par
Following periodontal examinations, subgingival biofilm was collected using a periodontal curette from the site with the greatest probing depth in each sextant (Hu-Friedy, USA). Samples were pooled in a microtube containing sterile PBS (one tube for each patient), and, after centrifugation, pellets were stored at -20ºC until DNA extraction. 
\section[{k) Bacterial DNA Extraction and Genotyping}]{k) Bacterial DNA Extraction and Genotyping}\par
Bacterial DNA was extracted from subgingival biofilm samples using a PureLink? Genomic DNA Mini Kit (Invitrogen) by the manufacturer's protocol.\par
The relative quantification of P. gingivalis was performed using the TaqMan ® probe quantitative realtime polymerase chain reaction (qPCR) method. The probe sequence used in the reaction was: 5'-6-FAM-CRA ACA GGA TTA GAT ACC CTG GTA GTC CRC-BHQ1 -3'. The primer sequence was: forward -5'-GAC TGA CAC TGA AGC ACG AAG -3' and reverse -5'-GCT TGA CGG TAT ATC GCA AAC TC -3'. The PCR mix (final volume of 12.5 µl) consisted of: 10xbuffer (1.25µl) containing 50mMMgCl 2 (0.38µl),4x2.5mM(1µl), 10 µM forward primer (0.38 µl), 10 µM reverse primer (0.38 µl), 5U/µl Taq (0.05 µl), RNase-free water (6.33 µl), 10 µM probe (0.25 µl) and DNA (2.5 µl). Reactions were performed using an initial denaturation cycle at 94ºC for 1 min, 45 cycles at 94ºC for 20 sec, and 58ºC for 35 sec. 
\section[{l) Statistical Analysis}]{l) Statistical Analysis}\par
Descriptive statistical analysis was carried out using the Student T-test for continuous variates and the chi-square test, or Fisher´s exact test, for dichotomous variates. Comparisons of IgG levels were made using the Mann-Whitney test. The association between periodontitis and severe asthma was evaluated by logistic regression, using the backward strategy to select confounders. All statistical analyses were performed using the SPSS v21 statistical package, and the results were considered statistically significant when p ? 0.05. 
\section[{III. Results}]{III. Results}\par
A total of 169 individuals were included in the study. The group with severe asthma (case) consisted of 53 Participants (31.4\%), while 116 participants (68.6\%) were included in the group without asthma (control). The mean age in the case group was 49.5±12.1 years, versus 43.95±11.4 years in the control group. In the case group, 45 (84.9\%) participants were female, and eight (15.1\%) were male, while the control group consisted of 100(86.2\%) females and 16 (13.8\%) males. No statistically significant differences were detected between the groups in terms of age (P=0.17) or sex (P=1.0), nor concerning the socioeconomic and demographic characteristics evaluated (Table \hyperref[tab_0]{1}), demonstrating homogeneity regarding these covariates.\par
Table \hyperref[tab_1]{2} delineates the distribution of aspects related to lifestyle habits and oral health in the groups with and without severe asthma. No statistically significant differences were observed between cases and controls concerning these aspects, except for mouth-breathing habit (P <0.01).\par
Table \hyperref[tab_2]{3} lists characteristics related to the general health status of the participants. While homogeneity was observed between the case and control groups, statistically significant differences were seen about diagnoses of periodontitis (P<0.01) and hypertension (P<0.01).\par
A positive association between periodontitis and severe asthma was observed (OR = 6.73 [2.57-17.64]), even after adjusting for mouth breathing, hypertension, body mass index (BMI) and practicing physical activity (OR=7.96 [2.65-23.9]). The frequency of periodontitis in the case group was 30.8\% versus 6\%, in the control group, i.e, the chance of having severe asthma was almost eight times higher among individuals with periodontitis.\par
The humoral evaluation found ,no statistically significant differences in levels of IgG specific to the crude extract (P=0.48) or rHmuY (P=0.90) between the case and control groups, as illustrated in Figures \hyperref[fig_2]{1 and  2}, respectively. Moreover, IgG levels specific to the crude extract (P=0.79) and to rHmuY (P=0.63) were similar among individuals with or without periodontitis, as shown in Figures \hyperref[fig_3]{3 and 4}, respectively. Also, we found no statistically significant differences in the relative amount of Porphyromonas gingivalis (P=0,05) among participants with severe asthma and those without asthma (Figure  {\ref 5}). Unexpectedly, significantly lower relative amounts of Porphyromonas gingivalis (P?0,001) were observed in the biofilm of individuals with periodontitis in comparison to those without periodontitis (Figure \hyperref[fig_5]{6}). 
\section[{IV. Discussion}]{IV. Discussion}\par
The main finding of the present study was the establishment of a strong association between periodontitis and asthma, even after adjusting for confounders, indicating that individuals with periodontitis are more likely to suffer from asthma. Another relevant result was similar production levels of IgG specific to P. gingivalis among the participants, regardless of whether they had severe asthma, periodontitis, or neither of these conditions. While the literature indicates that individuals with periodontitis are expected to harbor significantly higher levels of IgG specific to Porphyromonas gingivalis \hyperref[b16]{(17)} , the present results were divergent. This would seem to suggest that the presence of severe asthma may influence the humoral response to Porphyromonas gingivalis, the relative quantities of Porphyromonas gingivalis were found to be significantly lower in the subgingival biofilm of individuals with chronicperiodontitis.\par
To date, the literature is controversial regarding the relationship between periodontitis and asthma. Several studies have shown positive associations \hyperref[b6]{(7,}\hyperref[b22]{(23)}\hyperref[b23]{(24)}\hyperref[b24]{(25)}\hyperref[b25]{(26)} in individuals with periodontitis, who are five times as likely to present bronchial inflammation \hyperref[b5]{(6)} , or have a three times greater chance of developing severe asthma \hyperref[b26]{(27)} . By contrast, other studies have reported either a negative association \hyperref[b12]{(13)} or demonstrated the absence of any relationship between these diseases \hyperref[b10]{(11,}\hyperref[b11]{12)} .\par
Possibly due to this lack of concordance, there are no reports in the literature that attempt to confirm this association on a molecular level. To an effort to investigate this association, we sought to evaluate serum levels of IgG against antigens of Porphyromonas gingivalis, a keystone microorganism in periodontal dysbiosis \hyperref[b14]{(15,}\hyperref[b27]{28)} , which is prevalent in deep periodontal pockets \hyperref[b15]{(16)} .\par
In contrast to the findings reported herein, previous studies have shown that individuals with periodontitis present high levels of IgG specific to Porphyromonas gingivalis extract, as well as toitslipoprote in HmuY. The literature indicates a remarkable discrepancy regarding IgG levels in individuals with a clinical diagnosis of periodontitis, those with gingivitis, and others with sound periodontal health \hyperref[b17]{(18,}\hyperref[b18]{19,}\hyperref[b34]{35)} . Nevertheless, is important to emphasize that these studies did not include individuals diagnosed with any other diseases, nor those taking medications, such as corticosteroids, which like this eliminated agents capable of modulating host response.\par
Given this fact, it is possible to speculate that, in individuals with chronic periodontitis, the presence of severe asthma may modulate the production of IgG specific to Porphyromonas gingivalis, which reinforces the bidirectional association between these two diseases. Regardless, further investigation is necessary to clarify whether this modulation occurs by way of immune system regulation.\par
Furthermore, it is possible that the similarities seen in levels of IgG specific to the Porphyromonas gingivalis extract and HmuY, in individuals with and without severe asthma, may be related to possible interactions between periodontal tissues and the drugs used to control the clinical symptoms of asthma \hyperref[b22]{(23,}\hyperref[b24]{25)} . The immunosuppressant effect of corticosteroids can influence the host immune response seen in periodontal tissues, including the production of IgG \hyperref[b35]{(36)} . Moreover, it is possible that the presence of asthma provokes changes in the periodontal microenvironment, which may alter the colonization, in the subgingival biofilm, of members of the microbial community. Herein, surprisingly, the relative quantities of Porphyromonas gingivalis were found to be higher in individuals without periodontitis.\par
As previously mentioned, this microorganism is capable of modulating host defense by altering the growth and development of the entire microbial community, i.e. eliciting destructive changes in the relationships among its members, which is normally homeostatic. Porphyromonas gingivalis is considered to be a keystone pathogen that, when present even in low amounts in the biofilm, can provoke, an imbalance between host response and the biofilm, which may favor the onset and progression of periodontitis \hyperref[b14]{(15)} .\par
It is important to consider that some studies argue that the presence of periodontitis may offer protection against asthma. This is justified by the hygiene hypothesis, which holds that fewer opportunities for infection are responsible, at least in part, for increases in the prevalence of allergic diseases \hyperref[b10]{(11)}\hyperref[b11]{(12)}\hyperref[b12]{(13)} .\par
In this context, a study reported that Porphyromonas gingivalis can reduces inflammation in the airways, although this effect did not affect the hyperreactivity of these airways \hyperref[b13]{(14)} . Also, high concentrations of serum IgG against Porphyromonas gingivalis were also found to be significantly associated with a lower prevalence of asthma and sibilance (13)  . The present study represents an initial attempt to investigate the molecular aspects of the association between periodontitis and asthma. A link between levels of Porphyromonas gingivalis in the subgingival biofilm and, the humoral immune response against this bacterium was found. Moreover, the relative quantification of the bacterium was performed via a widely used sensitive technique. Also, the immunoassays employed to evaluate IgG levels were previously standardized, and the capacity to distinguish among a variety of periodontal conditions was also demonstrated \hyperref[b34]{(35)} .\par
About limitations, due to the present casecontrol design, there was no way to establish which disease preceded the other, as both are chronic diseases. The possibility of residual confoundment may also exist, since some covariates, such as genetic factors, may not have been considered.\par
Thus, in light of its limitations, the present study seems to suggest that the occurrence of severe asthma is capable of modulating the colonization of Porphyromonas gingivalis in the subgingival biofilm, in addition to the production of IgG specific to antigens of this bacterium (extract and HmuY) in the sera of individuals with periodontitis.         
\section[{Tables and Figures}]{Tables and Figures}\begin{figure}[htbp]
\noindent\textbf{1}\includegraphics[]{image-2.png}
\caption{\label{fig_1}Figure 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{2}\includegraphics[]{image-3.png}
\caption{\label{fig_2}Figure 2 :J}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{4}\includegraphics[]{image-4.png}
\caption{\label{fig_3}Figure 4 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{35}\includegraphics[]{image-5.png}
\caption{\label{fig_4}Figure 3 Figure 5 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{6}\includegraphics[]{image-6.png}
\caption{\label{fig_5}Figure 6 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{1} \par 
\begin{longtable}{P{0.85\textwidth}}
Association between Periodontitis and Severe Asthma: The Role of IgG Anti-Porphyromonas\\
gingivalis Levels\end{longtable} \par
 
\caption{\label{tab_0}Table 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{2} \par 
\begin{longtable}{P{0.85\textwidth}}
gingivalis Levels\end{longtable} \par
  {\small\itshape [Note: * Diagnosis of periodontitis according to GomesFilho et al 2007 ** p: significance level (? 0.05) Pearson's chi-square or Fisher's exact test]} 
\caption{\label{tab_1}Table 2 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{3} \par 
\begin{longtable}{P{0.26793478260869563\textwidth}P{0.2633152173913043\textwidth}P{0.2563858695652174\textwidth}P{0.06236413043478261\textwidth}}
\tabcellsep Without asthma\tabcellsep Severe asthma\tabcellsep \\
\tabcellsep (N=116)\tabcellsep (N=52)\tabcellsep \\
Hypertension\tabcellsep N (\%)\tabcellsep N (\%)\tabcellsep p**\\
Not\tabcellsep 95 (81,9\%)\tabcellsep 29 (54,7\%)\tabcellsep \\
Yes\tabcellsep 21(18,1\%)\tabcellsep 24(45,3\%)\tabcellsep \\
Diabetes\tabcellsep N (\%)\tabcellsep N (\%)\tabcellsep p**\\
Not\tabcellsep 109 (94,0\%)\tabcellsep 46(86,8\%)\tabcellsep 0,14\\
Yes\tabcellsep 7(6,0\%)\tabcellsep 7(13,2\%)\tabcellsep \\
Osteoporosis\tabcellsep N (\%)\tabcellsep N (\%)\tabcellsep p**\\
Not\tabcellsep 115(99,1\%)\tabcellsep 51(96,2\%)\tabcellsep 0,23\\
Yes\tabcellsep 1 (0,9\%)\tabcellsep 2 (3,8\%)\tabcellsep \\
Kidney disease\tabcellsep N (\%)\tabcellsep N (\%)\tabcellsep p**\\
Not\tabcellsep 115(99,1\%)\tabcellsep 53 (100\%)\tabcellsep 1,00\\
Yes\tabcellsep 1 (0,9\%)\tabcellsep 0(0\%)\tabcellsep \\
Hypercholesterolemia\tabcellsep N (\%)\tabcellsep N (\%)\tabcellsep p**\\
Not\tabcellsep 110 (94,8\%)\tabcellsep 46(86,8\%)\tabcellsep 0,01\\
Yes\tabcellsep 1(0,9\%)\tabcellsep 7(13,2\%)\tabcellsep \\
Cardiovascular disease\tabcellsep N (\%)\tabcellsep N (\%)\tabcellsep p**\\
Not\tabcellsep 115(99,1\%)\tabcellsep 84(93,3\%)\tabcellsep 0,04\\
Yes\tabcellsep 1 (0,9\%)\tabcellsep 6 (6,7\%)\tabcellsep \\
Body mass index (weight / height²)\tabcellsep N (\%)\tabcellsep N (\%)\tabcellsep p**\\
< 25\tabcellsep 42(36,2\%)\tabcellsep 11 (20,8\%)\tabcellsep 0,05\\
?25\tabcellsep 74 (63,8\%)\tabcellsep 42(79,2\%)\tabcellsep \\
Diagnosis of periodontitis *\tabcellsep N (\%)\tabcellsep N (\%)\tabcellsep p***\\
Without periodontitis\tabcellsep 109 (94\%)\tabcellsep 36(69,2\%)\tabcellsep <0,01\\
With periodontitis\tabcellsep 7 (6\%)\tabcellsep 16 (30,8\%)\tabcellsep \end{longtable} \par
  {\small\itshape [Note: * Diagnosis of periodontitis according to Gomes Filho et al 2007 ** p: significance level (? 0.05) Pearson's chi-square or Fisher's exact test]} 
\caption{\label{tab_2}Table 3 :}\end{figure}
 			\footnote{Association between Periodontitis and Severe Asthma: The Role of IgG Anti-Porphyromonas gingivalis Levels © 2020 Global Journals} 		 		\backmatter   			 
\subsection[{Acknowledgements}]{Acknowledgements}\par
To the Coordination for the Improvement of Higher Education Personnel (CAPES) of the Ministry of Education (MEC), the Postgraduate Program in Immunology (PPGIm) of the Federal University of Bahia (UFBA), ProAr and the Research Center, Integrated Practice and Multidisciplinary Research (NUPPIIM) at the State University of Feira de Santana (UEFS). 			  			  				\begin{bibitemlist}{1}
\bibitem[Zhang and Khl ()]{b33}\label{b33} 	 		‘A complex role for complement in allergic asthma’.  		 			X Zhang 		,  		 			J Khl 		.  	 	 		\textit{Expert Rev Clin Immunol}  		2010. 6  (2)  p. .  	 
\bibitem[Kohl et al. ()]{b31}\label{b31} 	 		‘A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma’.  		 			J Kohl 		,  		 			R Baelder 		,  		 			I P Lewkowich 		,  		 			M K Pandey 		,  		 			H W Hawlisch 		,  		 			L 		.  	 	 		\textit{J Clin Investig}  		2006. 116  (3)  p. .  	 
\bibitem[Trombelli and Fr ()]{b35}\label{b35} 	 		‘A review of factors influencing the incidence and severity of plaque-induced gingivitis’.  		 			L Trombelli 		,  		 			Fr 		.  	 	 		\textit{Minerva Stomatol}  		2013. 62  (6)  p. .  	 
\bibitem[Yaghobee et al. (2008)]{b6}\label{b6} 	 		‘Association between Asthma and Periodontal Disease’.  		 			S Yaghobee 		,  		 			M Paknejad 		,  		 			A Khorsand 		.  	 	 		\textit{J Dent}  		2008. December. 5 p. .  	 
\bibitem[Soledade-Marques et al. (2017)]{b26}\label{b26} 	 		‘Association between Periodontitis and Severe Asthma in Adults: A Case-Control Study’.  		 			K R Soledade-Marques 		,  		 			I S Gomes-Filho 		,  		 			Seixas Da Cruz 		,  		 			S De 		,  		 			Santana Passos-Soares 		,  		 			J Trindade 		,  		 			S C Cerqueira E De 		,  		 			MM 		.  	 	 		\textit{Oral DisI}  		2017. July. p. .  	 
\bibitem[Morjaria et al. ()]{b4}\label{b4} 	 		‘Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD’.  		 			J B Morjaria 		,  		 			M Malerba 		,  		 			R Polosa 		.  	 	 		\textit{Drug Discov Today}  		2010. 15  (9)  p. .  	 
\bibitem[Stensson et al. ()]{b24}\label{b24} 	 		‘Birkhed D. Caries Prevalence, Caries-Related Factors and Plaque pH in Adolescents with Long-Term Asthma’.  		 			M Stensson 		,  		 			L K Wendt 		,  		 			G Koch 		,  		 			G Oldaeus 		,  		 			P Ramberg 		.  	 	 		\textit{Caries Res}  		2010. 44 p. .  	 
\bibitem[Hajishengallis ()]{b14}\label{b14} 	 		‘Breaking bad: Manipulation of the host response by Porphyromonas gingivalis’.  		 			George Hajishengallis 		,  		 			Rjl 		.  	 	 		\textit{Eur J Immunol}  		2014. 44  (2)  p. .  	 
\bibitem[Sj and Me ()]{b8}\label{b8} 	 		‘Can oral pathogens influence allergic disease?’.  		 			Arbes SjJr 		,  		 			Me 		.  	 	 		\textit{J Allergy Clin Immunol}  		2011. 127  (5)  p. .  	 
\bibitem[Stensson et al. ()]{b25}\label{b25} 	 		‘Caries prevalence, cariesrelated factors and plaque pH in adolescents with long-term asthma’.  		 			M Stensson 		,  		 			L K Wendt 		,  		 			G Koch 		,  		 			G Oldaeus 		,  		 			P Lingström 		,  		 			D Birkhed 		.  	 	 		\textit{Caries Res}  		2011. 44  (6)  p. .  	 
\bibitem[Cukier ()]{b2}\label{b2} 	 		‘Comparação entre medidas objetivas do tabagismo e tabagismo autodeclarado em pacientes com asma ou DPOC: será que nossos pacientes dizem a verdade?’.  		 			R S Cukier 		.  	 	 		\textit{J Bras Pneumol}  		2015. 41  (2) .  	 
\bibitem[Laurikaines and Kuusisto ()]{b22}\label{b22} 	 		‘Comparison of the health status and salivary flow rate of asthmatic patients with those of nonasthmatic adults -results of a pilot study’.  		 			K Laurikaines 		,  		 			P Kuusisto 		.  	 	 		\textit{Allergy}  		1998. 53 p. .  	 
\bibitem[Lukacs et al. ()]{b29}\label{b29} 	 		‘Complementdependent immune complex-induced bronchial inflammation and hyperreactivity’.  		 			N W Lukacs 		,  		 			M M Glovsky 		,  		 			P A Ward 		.  	 	 		\textit{Am J Physiol Lung Cell Mol Physiol}  		2001. 280  (3)  p. .  	 
\bibitem[Gomes-Filho et al. ()]{b5}\label{b5} 	 		‘Does Periodontal Infection Have an Effect on Severe Asthma in Adults?’.  		 			I S Gomes-Filho 		,  		 			K R Soledade-Marques 		,  		 			Seixas Da Cruz 		,  		 			S De 		,  		 			Santana Passos-Soares 		,  		 			J Trindade 		,  		 			S C Souza-Machado 		,  		 			A 		.  	 	 		\textit{J Periodontol}  		2014. 85  (6)  p. .  	 
\bibitem[Gomes-Filho et al. ()]{b21}\label{b21} 	 		‘Exposure measurement in the association between periodontal disease and prematurity/low birth weight’.  		 			I S Gomes-Filho 		,  		 			S S Cruz 		,  		 			E J Rezende 		,  		 			Dos Santos 		,  		 			C A Soledade 		,  		 			K R Magalhães 		,  		 			M A De Azevedo 		,  		 			A C Trindade 		,  		 			S C Vianna 		,  		 			MI 		,  		 			Passos Jde 		,  		 			S Ce 		.  	 	 		\textit{J Clin Periodontol}  		2007. 34  (11)  p. .  	 
\bibitem[
			TH
		 ()]{b23}\label{b23} 	 		‘Gingival IgE and histamine concentrations in patients with asthma and in patients with periodontitis’.  		 			TH 		.  	 	 		\textit{J Clin Periodontol}  		1984. 11  (2)  p. .  	 
\bibitem[Gina ()]{b0}\label{b0} 	 		\textit{Global initiative for asthma. Global strategy for asthma management and prevention},  		 			Gina 		.  		 \url{Disponívelem:www.ginasthma.org.AcessadoemABRILde2016}  		2016.  	 
\bibitem[Franca et al. ()]{b16}\label{b16} 	 		‘Humoral immune response to antigens of Porphyromonas gingivalis ATCC 33277 in chronic periodontitis’.  		 			M Franca 		,  		 			L Moura-Costa 		,  		 			R J Meyer 		,  		 			S C Trindade 		,  		 			R Tunes U Da 		,  		 			S M Freire 		.  	 	 		\textit{J Appl Oral Sci}  		2007. 15  (3)  p. .  	 
\bibitem[Trindade et al. ()]{b18}\label{b18} 	 		‘Induction of interleukin (IL)-1?, IL-10, IL-8 and immunoglobulin G by Porphyromonas gingivalis HmuY in humans’.  		 			S C Trindade 		,  		 			Olczakt 		,  		 			I S Gomes-Filho 		,  		 			L F Moura-Costa 		,  		 			Emm Cerqueira 		,  		 			M Galdino-Neto 		.  	 	 		\textit{J Periodontal Res}  		2012. 47  (1)  p. .  	 
\bibitem[Friedrich et al. ()]{b11}\label{b11} 	 		‘Inverse association between periodontitis and respiratory allergies’.  		 			N Friedrich 		,  		 			H Völzke 		,  		 			C Schwahn 		,  		 			A Kramer 		,  		 			M Jünger 		,  		 			Schäfert 		,  		 			U John 		,  		 			Kt 		.  	 	 		\textit{Clin Exp Allergy}  		2006. 36  (4)  p. .  	 
\bibitem[Mehta et al. ()]{b3}\label{b3} 	 		‘Is bronchial asthma a risk factor for gingival diseases? A control study. N Y State Dent’.  		 			A Mehta 		,  		 			P S Sequeira 		,  		 			R C Sahoo 		,  		 			Kg 		.  	 	 		\textit{J}  		2009. 75  (1)  p. .  	 
\bibitem[Hujoel et al. ()]{b10}\label{b10} 	 		‘Longterm use of medications and destructive periodontal disease’.  		 			P P Hujoel 		,  		 			J Cunha-Cruz 		,  		 			G Maupome 		,  		 			Sb 		.  	 	 		\textit{J Periodontol}  		2008. 79  (8)  p. .  	 
\bibitem[Socransky et al. ()]{b15}\label{b15} 	 		‘Microbial complexes in subgingival plaque’.  		 			S S Socransky 		,  		 			A D Haffajee 		,  		 			M A Cugini 		,  		 			C Smith 		,  		 			Krj 		.  	 	 		\textit{J Clin Periodontol}  		1998. 36  (4)  p. .  	 
\bibitem[Card et al. ()]{b13}\label{b13} 	 		‘Modulation of allergic airway inflammation by the oral pathogen Porphyromonas gingivalis’.  		 			J W Card 		,  		 			M A Carey 		,  		 			J W Voltz 		,  		 			J A Bradbury 		,  		 			C D Ferguson 		,  		 			E A Cohen 		.  	 	 		\textit{Infect Immun}  		2010. 78  (6)  p. .  	 
\bibitem[Stensson et al. ()]{b7}\label{b7} 	 		‘Oral health in young adults with long-term, controlled asthma’.  		 			M Stensson 		,  		 			L-K Wendt 		,  		 			G Koch 		,  		 			G Oldaeus 		,  		 			P Ramberg 		,  		 			D Birkhed 		.  	 	 		\textit{Acta Odontol Scand}  		2011. 69  (3)  p. .  	 
\bibitem[Samuel et al. ()]{b12}\label{b12} 	 		‘Oral pathogens and allergic disease: Results from the Third National Health and Nutrition Examination Survey’.  		 			J Samuel 		,  		 			ArbesJr 		,  		 			Dds 		,  		 			Mph 		,  		 			Michelle L Phda 		,  		 			Sever 		,  		 			Ben Bsa 		,  		 			Vaughn 		,  		 			E A Msb 		,  		 			Bsa Cohen 		,  		 			Darryl C Zeldin Md 		.  	 	 		\textit{J Allergy Clin Immunol}  		2006. 118  (5)  p. .  	 
\bibitem[Rocha et al. ()]{b1}\label{b1} 	 		‘Periodontal disease and asthma: literature review’.  		 			K Rocha 		,  		 			S Marques 		,  		 			A Souza-Machado 		.  	 	 		\textit{Med Biol}  		2011. 10  (103)  p. .  	 
\bibitem[
			GH
		 ()]{b27}\label{b27} 	 		‘Periodontitis: from microbial immune subversion to systemic inflammation’.  		 			GH 		.  	 	 		\textit{Nat Rev Immunol}  		2015. 15  (1)  p. .  	 
\bibitem[Ec ()]{b9}\label{b9} 	 		‘Respiratory symptoms in asthma: the view through a wide-angle lens’.  		 			Ec 		.  	 	 		\textit{J Allergy Clin Immunol}  		2012. 130  (2)  p. .  	 
\bibitem[Nguyen et al. ()]{b19}\label{b19} 	 		‘Responses to Porphyromonas gingivalis Gingipain Adhesin Domains in Subjects with Chronic Periodontitis’.  		 			Ky-Anh Nguyen 		,  		 			Arthur A Decarlomp 		,  		 			Charles A Collyer Dbl 		,  		 			N H Humoral 		.  	 	 		\textit{Infect IMMUNITY}  		2004. 72  (3)  p. .  	 
\bibitem[Guor and Ward ()]{b30}\label{b30} 	 		‘Role of C5a in Inflammatory Responses’.  		 			-F Guor 		,  		 			P A Ward 		.  	 	 		\textit{Annu Rev Immunol}  		2005. 23  (1)  p. .  	 
\bibitem[Trindade et al. ()]{b17}\label{b17} 	 		‘Serum antibody levels against Porphyromonas gingivalis extract and its chromatographic fraction in chronic and aggressive periodontitis’.  		 			S C Trindade 		,  		 			I S Gomes-Filho 		,  		 			R Meyer 		,  		 			V L Vale 		,  		 			L Pugliese 		,  		 			Freire Sm 		.  	 	 		\textit{J Int Acad Periodontol}  		2008. 10 p. .  	 
\bibitem[Neil et al. ()]{b20}\label{b20} 	 		‘Serum Immunoglobulin G (IgG) and IgG Subclass Responses to the RgpA-Kgp Proteinase-Adhesin Complex of Porphyromonas gingivalis in Adult Periodontitis’.  		 			M Neil 		,  		 			Catherine L O'brien-Simpson 		,  		 			Peter S Black 		,  		 			Nada Bhogalsmc 		,  		 			Thomas J Slakeski 		,  		 			Higgins Aecr 		.  	 	 		\textit{Infect Immun}  		2000. 68  (5)  p. .  	 
\bibitem[Kim et al. ()]{b28}\label{b28} 	 		‘The many paths to asthma: phenotype shaped by innate and adaptive immunity’.  		 			H Y Kim 		,  		 			R H Dekruyff 		,  		 			Ud 		.  	 	 		\textit{Nat Immunol}  		2010. 11  (7)  p. .  	 
\bibitem[
			SK
		 ()]{b32}\label{b32} 	 		‘The role of PI3K in immune cells’.  		 			SK 		.  	 	 		\textit{Nat Immunol}  		2003. 4  (4)  p. .  	 
\bibitem[Cardoso and Trindade ()]{b34}\label{b34} 	 		\textit{Utilização De Diferentes Antígenos De Porphyromonas Gingivalis Para Avaliação Da Resposta Imune Humoral Na Periodontite Crônica},  		 			Kapa Cardoso 		,  		 			S C Trindade 		.  		2017.  		 			Universidade Federal da Bahia 		 	 
\end{bibitemlist}
 			 		 	 
\end{document}
